English
Home > Products > 119768-44-4

China 119768-44-4 Factory

We always believe that one's character decides products' quality, the details decides products' quality ,with the REALISTIC,EFFICIENT AND INNOVATIVE team spirit for 119768-44-4,CAS NO 119768-44-4,Repotrectinib intermediate,Repotrectinib advance intermediate,N-BOC-(R)-1-AMINO-2-PROPANOL, We are generally looking ahead to forming effective business associations with new clientele around the world.
119768-44-4, We supply OEM services and replacement parts to meet the varying needs of our customers. We supply competitive price for quality goods and we are going to make certain your shipment is handled quickly by our logistics department. We sincerely hope to have the opportunity to meet with you and see how we can help you further your own business.

Related Products

Hot Products

  • LOXO-292

    LOXO-292

    Product Name:LOXO-292
    Molecular Formula:C29H31N7O3
    Molecular Weight;525.6
    CAS Registry Number;2152628-33-4
  • L-Leucine

    L-Leucine

    Product Name:L-Leucine
    Molecular Formula:C6H13NO2
    Molecular Weight:131.17
    CAS Registry Number:61-90-5
  • FLURBIPROFEN SODIUM (200 MG)

    FLURBIPROFEN SODIUM (200 MG)

    Product Name:FLURBIPROFEN SODIUM (200 MG)
    Molecular Formula:C15H12FO2.Na
    Molecular Weight;266.246
    CAS Registry Number;56767-76-1
  • Ramatroban

    Ramatroban

    Product Name:Ramatroban
    Molecular Formula:C21H21FN2O4S
    Molecular Weight;416.47
    CAS Registry Number;116649-85-5
  • 7-ketolithocholic Methyl ester

    7-ketolithocholic Methyl ester

    Product Name:7-ketolithocholic Methyl ester
    Molecular Formula:C25H40O4
    Molecular Weight:404.59
    CAS Registry Number:10538-59-7
  • 2-Chloro-4-fluorophenol

    2-Chloro-4-fluorophenol

    Product Name:2-Chloro-4-fluorophenol
    Molecular Formula:C6H4ClFO
    Molecular Weight:146.55
    CAS Registry Number:1996-41-4
  • Related Blog
  • Reviews

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • What is an Active Pharmaceutical Ingredient (API in Pharma)?

    Sandoo Pharmaceutical is a professional active pharmaceutical intermediate manufacturer, producing high quality APIs. Sandoo Pharmaceutical provides a wide range of active pharmaceutical intermediates.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products can be produced in ordinary chemical plants without obtaining a pharmaceutical production license. As long as the technical indicators meet certain level requirements, they can be used to participate in the synthesis and production of drugs.

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Related Search

CAS NO 119768-44-4

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept